# A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

> **NCT07269756** · PHASE1 · COMPLETED · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** HRS-7535 Tablets
- **DRUG:** Paracetamol Tablets
- **DRUG:** Digoxin Tablets
- **DRUG:** Rosuvastatin Calcium Tablets
- **DRUG:** Omeprazole Enteric-coated Capsules

## Key facts

- **NCT ID:** NCT07269756
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-12-08
- **Primary completion:** 2026-03-08
- **Final completion:** 2026-03-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269756, "A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07269756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*